Vizora日本語

Fuji PharmaFuji Pharma Co.,Ltd.4554東証プライム医薬品FY ending Sep 2025, consolidated, J-GAAP

Fuji Pharma revenue and profit

Out of every ¥100 of sales, about ¥10 is left as operating profit. Revenue changed +12.0% from the prior year, operating profit +28.6%.

Five-year trend

Revenue¥51.7B
FY ending Sep 2021: ¥34B¥34BFY ending Sep 2022: ¥35.4B¥35.4BFY ending Sep 2023: ¥40.9B¥40.9BFY ending Sep 2024: ¥46.1B¥46.1BFY ending Sep 2025: ¥51.7B¥51.7BFY21FY22FY23FY24FY25
Operating income¥4.99B
FY ending Sep 2021: ¥3.35B¥3.35BFY ending Sep 2022: ¥3.78B¥3.78BFY ending Sep 2023: ¥3.86B¥3.86BFY ending Sep 2024: ¥3.88B¥3.88BFY ending Sep 2025: ¥4.99B¥4.99BFY21FY22FY23FY24FY25
Operating margin9.7%
FY ending Sep 2021: 9.9%9.9%FY ending Sep 2022: 10.7%10.7%FY ending Sep 2023: 9.4%9.4%FY ending Sep 2024: 8.4%8.4%FY ending Sep 2025: 9.7%9.7%FY21FY22FY23FY24FY25

What drives ROE

Net margin × asset turnover = ROA; ROA × financial leverage = ROE

Net margin5.8%
Asset turnover0.56×
ROA3.3%
ROA3.3%
Financial leverage2.13×
ROE7.0%

Denominators: average assets and average equity. Derived from reported values; ROE is shown only for positive profit and equity.

Net margin5.8%
2021: 7.2%7.2%2022: 7.6%7.6%2023: 8.4%8.4%2024: 13.3%13.3%2025: 5.8%5.8%2122232425
Asset turnover0.56×
2021: 0.53×0.53×2022: 0.51×0.51×2023: 0.51×0.51×2024: 0.53×0.53×2025: 0.56×0.56×2122232425
ROA3.3%
2021: 3.8%3.8%2022: 3.9%3.9%2023: 4.3%4.3%2024: 7.0%7.0%2025: 3.3%3.3%2122232425
Financial leverage2.13×
2021: 1.99×1.99×2022: 2.10×2.10×2023: 2.27×2.27×2024: 2.23×2.23×2025: 2.13×2.13×2122232425
ROE7.0%
2021: 7.5%7.5%2022: 8.1%8.1%2023: 9.7%9.7%2024: 15.6%15.6%2025: 7.0%7.0%2122232425
PeriodNet marginAsset turnoverROAFinancial leverageROE
20217.2%0.53×3.8%1.99×7.5%
20227.6%0.51×3.9%2.10×8.1%
20238.4%0.51×4.3%2.27×9.7%
202413.3%0.53×7.0%2.23×15.6%
20255.8%0.56×3.3%2.13×7.0%

Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.

Asset intensity and goodwill

Annual trends in tangible-asset ratios and goodwill balance.

PPE ÷ revenue40.5%
2020: 37.8%37.8%2021: 42.3%42.3%2022: 53.0%53.0%2023: 50.3%50.3%2024: 45.3%45.3%2025: 40.5%40.5%202122232425
PPE ÷ total assets22.4%
2020: 20.6%20.6%2021: 22.4%22.4%2022: 24.8%24.8%2023: 24.1%24.1%2024: 23.2%23.2%2025: 22.4%22.4%202122232425
Goodwill ÷ parent equity—
2020: 2.9%2.9%2021: 2.7%2.7%2022: 2.0%2.0%2023: 1.1%1.1%2024: 0.2%0.2%202122232425
Goodwill balance—
2020: ¥1.14B¥1.14B2021: ¥865M¥865M2022: ¥691M¥691M2023: ¥412M¥412M2024: ¥88M¥88M202122232425

Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition

Investment and working-capital efficiency

Track R&D investment and how long operating capital remains tied up before sales turn into cash.

R&D spending¥3.34B
2020: ¥3.06B¥3.06B2021: ¥2.45B¥2.45B2022: ¥2.48B¥2.48B2023: ¥3.18B¥3.18B2024: ¥3.4B¥3.4B2025: ¥3.34B¥3.34B202122232425
R&D / revenue6.5%
2020: 9.1%9.1%2021: 7.2%7.2%2022: 7.0%7.0%2023: 7.8%7.8%2024: 7.4%7.4%2025: 6.5%6.5%202122232425
Receivable days—
2020: 126d126d2021: 127d127d202122232425
Payable days54d
2020: 71d71d2021: 108d108d2022: 109d109d2023: 85d85d2024: 53d53d2025: 54d54d202122232425

R&D is shown only for years with machine-readable disclosure. Days are estimates using year-end receivables, inventory and payables divided by annual revenue or cost of sales; financial companies are excluded.

Income statement (JPY millions)

ItemFY ending Sep 2021FY ending Sep 2022FY ending Sep 2023FY ending Sep 2024FY ending Sep 2025
Revenue33,99035,42640,88946,13851,677
Cost of revenue19,23920,86724,37428,29430,914
Gross profit14,75114,55816,51417,84420,763
SG&A11,40210,78112,65613,96315,773
Operating income3,3493,7773,8583,8804,990
Pretax income3,3713,7234,3998,2764,000
Income tax9381,0269632,1281,000
Net income attributable to owners2,4322,6963,4356,1463,000
Operating margin9.9%10.7%9.4%8.4%9.7%

Balance sheet (reported items)

Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.

Assets

8%
Property, plant and equipment 22%
Intangibles and goodwill 15%
5%
Other assets 50%

Funding

5%
Interest-bearing debt 26%
Other liabilities 19%
Equity 50%
0%

Each bar totals 100% of assets; other is the residual.

ItemFY ending Sep 2021FY ending Sep 2022FY ending Sep 2023FY ending Sep 2024FY ending Sep 2025
Cash and equivalents¥10.2B¥3.55B¥2.32B¥4.58B¥7.25B
Total assets¥64.2B¥75.5B¥85.3B¥90B¥93.4B
Net assets¥32.7B¥35.8B¥41.2B¥45.6B¥46.9B
Share capital¥3.8B¥3.8B¥3.8B¥3.8B¥3.9B
Trade receivables¥11.9B————
Property, plant and equipment¥14.4B¥18.8B¥20.5B¥20.9B¥20.9B
Intangible assets excluding goodwill¥2.4B¥10.4B¥10.5B¥12.4B¥13.9B
Goodwill¥865M¥691M¥412M¥88M—
Investment securities¥7.76B¥7.34B¥10.6B¥7.09B¥5.09B
Current assets¥34.8B¥34.7B¥39.1B¥42.5B¥47.9B
Current liabilities¥20.2B¥24B¥29.8B¥35.8B¥31B
Trade payables¥5.71B¥6.25B¥5.67B¥4.14B¥4.57B
Short-term borrowings¥7B¥8.3B¥11.3B¥15.3B¥15.3B
Long-term borrowings¥6.63B¥11.2B¥6.58B¥83M¥7.2B
Bonds——¥2.1B¥1.5B¥1.75B
Interest-bearing debt——¥20Bderived¥16.9Bderived¥24.3Bderived
Total liabilities¥31.6B¥39.7B¥44.2B¥44.4B¥46.5B
Non-controlling interests¥1M¥2M¥2M¥3M¥3M
Equity attributable to owners of parent¥32.2B¥34.2B¥36.7B¥42B¥44.1B
Retained earnings¥24.6B¥26.5B¥29.1B¥34.3B¥36.2B
Treasury stock-¥590M-¥579M-¥567M-¥505M-¥498M

Sources

Show source documents (6)

  • EDINET (FSA Japan)

    有価証券報告書－第61期(2024/10/01－2025/09/30)

    ID S100XAU22025-12-18Open

  • EDINET (FSA Japan)

    有価証券報告書－第60期(2023/10/01－2024/09/30)

    ID S100UZR22024-12-23Open

  • EDINET (FSA Japan)

    有価証券報告書－第59期(2022/10/01－2023/09/30)

    ID S100SI942023-12-21Open

  • EDINET (FSA Japan)

    有価証券報告書－第58期(令和3年10月1日－令和4年9月30日)

    ID S100PTQF2022-12-21Open

  • EDINET (FSA Japan)

    有価証券報告書－第57期(令和2年10月1日－令和3年9月30日)

    ID S100N2LZ2021-12-20Open

  • EDINET (FSA Japan)

    有価証券報告書－第56期(令和1年10月1日－令和2年9月30日)

    ID S100KDTI2020-12-18Open

Extracted from XBRL: 52 / Derived from other figures: 2

Spotted an error? Report it (corrections keep the original record)

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.

Open MarkdownShare on XSave image